• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物制剂时代炎症性肠病急诊就诊和住院率的趋势。

Trends in emergency department visits and hospitalization rates for inflammatory bowel disease in the era of biologics.

机构信息

Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.

Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.

出版信息

PLoS One. 2019 Jan 16;14(1):e0210703. doi: 10.1371/journal.pone.0210703. eCollection 2019.

DOI:10.1371/journal.pone.0210703
PMID:30650133
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6334964/
Abstract

BACKGROUND

The use of biologics in inflammatory bowel disease (IBD) has increased recently. However, studies on whether the proportion of IBD patient visits to the emergency department (ED) has decreased are scarce. We investigated the trends in IBD-related ED visits and hospitalization rates.

METHODS

Medical records of IBD-related visits to the ambulatory department (AD) and the ED of the Seoul National University Bundang Hospital in 2007, 2009, 2012, and 2014 were reviewed. Multiple-variable logistic regression analysis was used to identify significant risk factors for hospitalization.

RESULTS

The proportion of IBD patients who visited ED was 12.3% in 2007, 9.7% in 2009, 8.3% in 2012, and 6.4% in 2014 (P = 0.002). The most common chief complaints were abdominal pain (66.9%) in Crohn's disease (CD) patients and hematochezia (36.5%) in ulcerative colitis (UC) patients. The hospitalization rate following ED visits was 47.2% in CD patients and 55.6% in UC patients (P = 0.100). Multiple-variable analysis showed that significant risk factors associated with hospitalization in CD were aggressive disease behavior (odds ratio[OR] 3.54, P = 0.017) and presence of steroid exposure (OR 2.35, P = 0.047). Elevated C-reactive protein (CRP) (>0.5 mg/dL) (OR 5.40, P = 0.016) was the only risk factor associated with hospitalization in UC.

CONCLUSIONS

The proportion of ED visits decreased from 2007 to 2014; there was no significant change in hospitalization rates. Disease behavior/presence of steroid exposure and elevated CRP were associated with hospitalization among CD and UC patients who visited the ED, respectively.

摘要

背景

生物制剂在炎症性肠病(IBD)中的应用最近有所增加。然而,关于 IBD 患者就诊于急诊部(ED)的比例是否下降的研究却很少。我们调查了 IBD 相关 ED 就诊和住院率的趋势。

方法

回顾了 2007 年、2009 年、2012 年和 2014 年在首尔国立大学盆唐医院的 IBD 相关门诊(AD)和 ED 就诊的病历。采用多变量逻辑回归分析确定住院的显著危险因素。

结果

2007 年、2009 年、2012 年和 2014 年 ED 就诊的 IBD 患者比例分别为 12.3%、9.7%、8.3%和 6.4%(P = 0.002)。最常见的主要症状是克罗恩病(CD)患者的腹痛(66.9%)和溃疡性结肠炎(UC)患者的血便(36.5%)。ED 就诊后住院率在 CD 患者中为 47.2%,在 UC 患者中为 55.6%(P = 0.100)。多变量分析显示,与 CD 患者住院相关的显著危险因素是侵袭性疾病行为(比值比[OR]3.54,P = 0.017)和类固醇暴露(OR 2.35,P = 0.047)。C 反应蛋白(CRP)升高(>0.5 mg/dL)(OR 5.40,P = 0.016)是与 UC 患者住院相关的唯一危险因素。

结论

从 2007 年到 2014 年,ED 就诊的比例有所下降;住院率没有显著变化。疾病行为/类固醇暴露的存在和 CRP 升高分别与 CD 和 UC 患者 ED 就诊的住院有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02da/6334964/4b0dbb066c27/pone.0210703.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02da/6334964/c54531eff751/pone.0210703.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02da/6334964/87d90938a615/pone.0210703.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02da/6334964/31a882fe6a75/pone.0210703.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02da/6334964/4b0dbb066c27/pone.0210703.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02da/6334964/c54531eff751/pone.0210703.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02da/6334964/87d90938a615/pone.0210703.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02da/6334964/31a882fe6a75/pone.0210703.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02da/6334964/4b0dbb066c27/pone.0210703.g004.jpg

相似文献

1
Trends in emergency department visits and hospitalization rates for inflammatory bowel disease in the era of biologics.生物制剂时代炎症性肠病急诊就诊和住院率的趋势。
PLoS One. 2019 Jan 16;14(1):e0210703. doi: 10.1371/journal.pone.0210703. eCollection 2019.
2
Emergency department utilisation for inflammatory bowel disease in the United States from 2006 to 2014.美国 2006 年至 2014 年炎症性肠病急诊就诊情况。
Aliment Pharmacol Ther. 2018 Apr;47(7):913-921. doi: 10.1111/apt.14551. Epub 2018 Feb 7.
3
Analysis of Hospital-Based Emergency Department Visits for Inflammatory Bowel Disease in the USA.美国基于医院的炎症性肠病急诊科就诊情况分析。
Dig Dis Sci. 2016 Feb;61(2):389-99. doi: 10.1007/s10620-015-3895-2. Epub 2015 Sep 30.
4
Emergency Department Visits Related to Inflammatory Bowel Disease: Results From Nationwide Emergency Department Sample.与炎症性肠病相关的急诊科就诊情况:来自全国急诊科样本的结果
J Pediatr Gastroenterol Nutr. 2015 Sep;61(3):282-4. doi: 10.1097/MPG.0000000000000815.
5
Health Care utilization in elderly onset inflammatory bowel disease: a population-based study.老年起病炎症性肠病的医疗保健利用情况:一项基于人群的研究。
Inflamm Bowel Dis. 2015 Apr;21(4):777-82. doi: 10.1097/MIB.0000000000000306.
6
The Impact of Cannabis Use on Clinical Outcomes in Inflammatory Bowel Disease: A Population-based Longitudinal Cohort Study.大麻使用对炎症性肠病临床结局的影响:基于人群的纵向队列研究。
Inflamm Bowel Dis. 2024 Jul 3;30(7):1055-1061. doi: 10.1093/ibd/izad151.
7
Benefits of implementing a rapid access clinic in a high-volume inflammatory bowel disease center: Access, resource utilization and outcomes.在高容量炎症性肠病中心实施快速通道诊所的益处:就诊途径、资源利用和结果。
World J Gastroenterol. 2020 Feb 21;26(7):759-769. doi: 10.3748/wjg.v26.i7.759.
8
Assessing National Trends and Disparities in Ambulatory, Emergency Department, and Inpatient Visits for Inflammatory Bowel Disease in the United States (2005-2016).评估美国 2005-2016 年炎性肠病门诊、急诊和住院就诊的国家趋势和差异。
Clin Gastroenterol Hepatol. 2020 Oct;18(11):2500-2509.e1. doi: 10.1016/j.cgh.2020.01.023. Epub 2020 Jan 25.
9
Trends in hospitalization rates for inflammatory bowel disease in the United States.美国炎症性肠病住院率的趋势。
Clin Gastroenterol Hepatol. 2007 May;5(5):597-601. doi: 10.1016/j.cgh.2007.01.015. Epub 2007 Mar 26.
10
Predictive factors for clinically actionable computed tomography findings in inflammatory bowel disease patients seen in the emergency department with acute gastrointestinal symptoms.预测因子对在急诊科就诊的有急性胃肠道症状的炎症性肠病患者的临床可操作的计算机断层扫描发现。
J Crohns Colitis. 2014 Jun;8(6):504-12. doi: 10.1016/j.crohns.2013.11.003. Epub 2013 Nov 23.

引用本文的文献

1
Clinical and health care utilization variables can predict 90-day hospital re-admission in adults with Crohn's disease for point of care risk evaluation.临床和医疗保健利用变量可预测成人克罗恩病患者 90 天内的再次住院,以便进行即时护理风险评估。
BMC Gastroenterol. 2024 May 17;24(1):172. doi: 10.1186/s12876-024-03226-7.
2
The Role of Biomarkers in Surgery for Ulcerative Colitis: A Review.生物标志物在溃疡性结肠炎手术中的作用:综述
J Clin Med. 2021 Jul 29;10(15):3362. doi: 10.3390/jcm10153362.
3
Risk Factors for and Frequency of CT Scans, Steroid Use, and Repeat Visits in Inflammatory Bowel Disease Patients Seen at a Single-Center Emergency Department: A Retrospective Cohort Study.

本文引用的文献

1
Trends in health-care costs and utilization for inflammatory bowel disease from 2010 to 2014 in Korea: A nationwide population-based study.2010 年至 2014 年韩国炎症性肠病的医疗保健费用和利用趋势:一项全国性基于人群的研究。
J Gastroenterol Hepatol. 2018 Apr;33(4):847-854. doi: 10.1111/jgh.14027. Epub 2018 Feb 6.
2
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.21 世纪全球炎症性肠病的发病率和流行率:基于人群的系统综述研究。
Lancet. 2017 Dec 23;390(10114):2769-2778. doi: 10.1016/S0140-6736(17)32448-0. Epub 2017 Oct 16.
3
单中心急诊科炎症性肠病患者CT扫描、使用类固醇及复诊的风险因素与频率:一项回顾性队列研究
J Clin Med. 2021 Jun 17;10(12):2679. doi: 10.3390/jcm10122679.
4
Trends in US emergency department visits and subsequent hospital admission among patients with inflammatory bowel disease presenting with abdominal pain: a real-world study from a national emergency department sample database.美国炎症性肠病伴腹痛患者急诊就诊及随后住院情况的趋势:一项基于国家急诊样本数据库的真实世界研究
J Mark Access Health Policy. 2021 Apr 19;9(1):1912924. doi: 10.1080/20016689.2021.1912924.
5
Biologic therapy is associated with a mild decrease in the rate of hospitalizations in pediatric IBD.生物疗法与儿科 IBD 患者住院率的轻度下降有关。
BMC Pediatr. 2021 Feb 4;21(1):63. doi: 10.1186/s12887-021-02526-1.
6
Prediction of Recurrent Emergency Department Visits among Patients with Crohn's Disease: A Retrospective Study.克罗恩病患者急诊科再就诊的预测:一项回顾性研究
J Clin Med. 2020 Nov 13;9(11):3651. doi: 10.3390/jcm9113651.
7
Correction: Trends in emergency department visits and hospitalization rates for inflammatory bowel disease in the era of biologics.更正:生物制剂时代炎症性肠病的急诊科就诊趋势和住院率
PLoS One. 2019 May 7;14(5):e0216768. doi: 10.1371/journal.pone.0216768. eCollection 2019.
Incidence and Clinical Outcomes of Inflammatory Bowel Disease in South Korea, 2011-2014: A Nationwide Population-Based Study.
2011 - 2014年韩国炎症性肠病的发病率及临床结局:一项基于全国人口的研究
Dig Dis Sci. 2017 Aug;62(8):2102-2112. doi: 10.1007/s10620-017-4640-9. Epub 2017 Jun 7.
4
Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis.系统评价与荟萃分析:免疫抑制剂和生物制剂在减少克罗恩病和溃疡性结肠炎住院和手术方面的疗效比较。
Aliment Pharmacol Ther. 2017 Jan;45(1):3-13. doi: 10.1111/apt.13847. Epub 2016 Nov 10.
5
Predictors of Emergency Department Use by Persons with Inflammatory Bowel Diseases: A Population-based Study.炎症性肠病患者急诊科使用情况的预测因素:一项基于人群的研究。
Inflamm Bowel Dis. 2016 Dec;22(12):2907-2916. doi: 10.1097/MIB.0000000000000965.
6
Changing epidemiological trends of inflammatory bowel disease in Asia.亚洲炎症性肠病流行病学趋势的变化
Intest Res. 2016 Apr;14(2):111-9. doi: 10.5217/ir.2016.14.2.111. Epub 2016 Apr 27.
7
Analysis of Hospital-Based Emergency Department Visits for Inflammatory Bowel Disease in the USA.美国基于医院的炎症性肠病急诊科就诊情况分析。
Dig Dis Sci. 2016 Feb;61(2):389-99. doi: 10.1007/s10620-015-3895-2. Epub 2015 Sep 30.
8
Incidence and natural course of inflammatory bowel disease in Korea, 2006-2012: a nationwide population-based study.2006 - 2012年韩国炎症性肠病的发病率及自然病程:一项基于全国人口的研究
Inflamm Bowel Dis. 2015 Mar;21(3):623-30. doi: 10.1097/MIB.0000000000000313.
9
The incidence rate of colectomy for medically refractory ulcerative colitis has declined in parallel with increasing anti-TNF use: a time-trend study.抗 TNF 治疗的应用增加与溃疡性结肠炎药物难治性患者行结肠切除术的发生率下降平行:一项时间趋势研究。
Aliment Pharmacol Ther. 2014 Sep;40(6):629-38. doi: 10.1111/apt.12873. Epub 2014 Jul 13.
10
Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies.炎症性肠病手术风险随时间推移而降低:基于人群的系统评价和荟萃分析。
Gastroenterology. 2013 Nov;145(5):996-1006. doi: 10.1053/j.gastro.2013.07.041. Epub 2013 Jul 27.